Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 7/2005

01-07-2005 | Original Paper

Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma

Authors: T. Valković, D. Fučkar, S. Štifter, K. Matušan, M. Hasan, F. Dobrila, N. Jonjić

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2005

Login to get access

Abstract

Purpose and method: Monocyte chemotactic protein-1 (MCP-1) is a chemokine involved in the macrophage infiltration of tumor tissue. Tumor-associated macrophages (TAMs) are a population of mononuclear phagocytic cells that can have a complex function in tumor biology. The aim of this study was to determine the possible correlation between parenchymal MCP-1 expression and TAM level by immunohistochemical analysis of 97 invasive ductal breast carcinomas, not otherwise specified (NOS), and to investigate their relation with tumor size, histological grade, mitotic activity index (MAI) and lymph node status. Secondly, the MCP-1 mRNA was determined by reverse transcriptase–polymerase chain reaction (RT-PCR) in eight samples of normal breast tissue and 27 samples of invasive breast carcinomas and compared with TAMs. Results: MCP-1 immunoreactivity was present in tumor cells (17/97), but also in TAMs, fibroblasts and endothelial cells. The statistical analysis did not show a significant correlation between MCP-1 expression in tumoral epithelium and tumor size, histological grade, MAI, lymph node status or TAMs. The results of RT-PCR showed that, in all cases of breast carcinomas (27/27) and the majority of normal breast tissues (7/8), the number of detected MCP-1 cDNA copies was above the detection limit. However, carcinomas showed higher levels of MCP-1 mRNA than normal breast tissue. Nevertheless, the statistical analysis did not find a significant correlation between MCP-1 expression and macrophage infiltrations. Conclusion: These results indicate that MCP-1 is probably not the only and/or crucial factor involved in macrophage attraction to tumor locus in breast carcinoma.
Literature
go back to reference Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254–256CrossRefPubMed Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254–256CrossRefPubMed
go back to reference Botazzi B, Polentarutti N, Acero R, Balsari A, Boraschi P, Ghezzi P, et al (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220:210–212PubMed Botazzi B, Polentarutti N, Acero R, Balsari A, Boraschi P, Ghezzi P, et al (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220:210–212PubMed
go back to reference Elston CW, Ellis IO (1991) Pathological prognostic factors in breast carcinoma. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410 Elston CW, Ellis IO (1991) Pathological prognostic factors in breast carcinoma. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19:403–410
go back to reference Evans R (1972) Macrophages in syngenic animal tumours. Transplantation 14:468–473PubMed Evans R (1972) Macrophages in syngenic animal tumours. Transplantation 14:468–473PubMed
go back to reference Goede V, Brogelli L, Ziche M, Augustin HG (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82:756–770CrossRef Goede V, Brogelli L, Ziche M, Augustin HG (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82:756–770CrossRef
go back to reference Graves DT, Jiang YL, Williamson A, Valente AJ (1989) Identification of monocyte chemotactic activity produced by malignant cells. Science 245:1490–1492PubMed Graves DT, Jiang YL, Williamson A, Valente AJ (1989) Identification of monocyte chemotactic activity produced by malignant cells. Science 245:1490–1492PubMed
go back to reference Graves DT, Barnhill R, Galanopoulos T, Antoniades HN (1992) Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140:9–14PubMed Graves DT, Barnhill R, Galanopoulos T, Antoniades HN (1992) Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140:9–14PubMed
go back to reference Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y (2000) Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7:263–269CrossRefPubMed Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y (2000) Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7:263–269CrossRefPubMed
go back to reference Hayashida K, Nanki T, Girschich H, Yavuz S, Oshi T, Lipsky PE (2001) Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 3:118–126CrossRefPubMed Hayashida K, Nanki T, Girschich H, Yavuz S, Oshi T, Lipsky PE (2001) Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 3:118–126CrossRefPubMed
go back to reference Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitnech G, Leodolter S, et al (1999) Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 81:855–859CrossRefPubMed Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitnech G, Leodolter S, et al (1999) Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 81:855–859CrossRefPubMed
go back to reference Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K (1999) Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 19:1179–1182CrossRefPubMed Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K (1999) Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 19:1179–1182CrossRefPubMed
go back to reference Jonjić N, Valković T, Lučin K, Iternička Z, Krstulja M, Mustać E, et al (1998) Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res 18:3767–3770PubMed Jonjić N, Valković T, Lučin K, Iternička Z, Krstulja M, Mustać E, et al (1998) Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res 18:3767–3770PubMed
go back to reference Kraemer R (2000) Regulation of cell migration in atherosclerosis. Curr Atheroscler Rep 2:445–452PubMed Kraemer R (2000) Regulation of cell migration in atherosclerosis. Curr Atheroscler Rep 2:445–452PubMed
go back to reference Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, et al (1983) Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62:271–273PubMed Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, et al (1983) Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62:271–273PubMed
go back to reference Mantovani A, Ming WJ, Balotta C, Abdeljalil B, Botazzi B (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factors. Biochem Biophys Acta 865:59–67PubMed Mantovani A, Ming WJ, Balotta C, Abdeljalil B, Botazzi B (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factors. Biochem Biophys Acta 865:59–67PubMed
go back to reference Mussoni L, Riganti M, Acero R, Erroi A, Conforti G, Mantovani A, et al (1988) Macrophages associated with murine tumours express plasminogen activator activity. Int J Cancer 41:227–230PubMed Mussoni L, Riganti M, Acero R, Erroi A, Conforti G, Mantovani A, et al (1988) Macrophages associated with murine tumours express plasminogen activator activity. Int J Cancer 41:227–230PubMed
go back to reference Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391–2396PubMed Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391–2396PubMed
go back to reference Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S (2000) Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121:437–444CrossRefPubMed Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S (2000) Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121:437–444CrossRefPubMed
go back to reference Peri G, Milanes C, Matteucci C, Ruco L, Zhou D, Sozzani S, et al (1994) A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 174:249–257CrossRefPubMed Peri G, Milanes C, Matteucci C, Ruco L, Zhou D, Sozzani S, et al (1994) A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 174:249–257CrossRefPubMed
go back to reference Polverini PJ, Laibovich SJ (1984) Induction of neovascularisation in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 51:635–642PubMed Polverini PJ, Laibovich SJ (1984) Induction of neovascularisation in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 51:635–642PubMed
go back to reference Pyke C, Gream N, Ralfkiaer E, Ronne E, Hoyer Hansen G, Brunner N, et al (1993a) Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911–1915PubMed Pyke C, Gream N, Ralfkiaer E, Ronne E, Hoyer Hansen G, Brunner N, et al (1993a) Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911–1915PubMed
go back to reference Pyke C, Ralfkiaer E, Tryggvason K, Dano K (1993b) Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142:359–365PubMed Pyke C, Ralfkiaer E, Tryggvason K, Dano K (1993b) Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142:359–365PubMed
go back to reference Sato K, Kuratsu JI, Takeshima H, Yoshimura T, Ushio Y (1995) Expression of monocyte chemoattractant protein-1 in meningioma. J Neurosurg 82:874–878PubMed Sato K, Kuratsu JI, Takeshima H, Yoshimura T, Ushio Y (1995) Expression of monocyte chemoattractant protein-1 in meningioma. J Neurosurg 82:874–878PubMed
go back to reference Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y (1994) Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80:1056–1062PubMed Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y (1994) Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 80:1056–1062PubMed
go back to reference Ueono T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis and survival in human breast cancer. Clin Cancer Res 6:3282–3289PubMed Ueono T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis and survival in human breast cancer. Clin Cancer Res 6:3282–3289PubMed
go back to reference Valković T, Lučin K, Krstulja M, Dobi-Babić R, Jonjić N (1998) Expression of monocyte chemotactic protein-1 in human invasive ductal breast carcinoma. Pathol Res Pract 194:335–340PubMed Valković T, Lučin K, Krstulja M, Dobi-Babić R, Jonjić N (1998) Expression of monocyte chemotactic protein-1 in human invasive ductal breast carcinoma. Pathol Res Pract 194:335–340PubMed
go back to reference Valković T, Dobrila F, Melato M, Sasso F, Jonjić N (2002) Correlation between vascular endothelial growth factor, angiogenesis and tumor associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440:583–588CrossRefPubMed Valković T, Dobrila F, Melato M, Sasso F, Jonjić N (2002) Correlation between vascular endothelial growth factor, angiogenesis and tumor associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440:583–588CrossRefPubMed
go back to reference Wu S, Boyer CM, Whitaker RS, Berchuch A, Wienberg JB, Bast RCJ (1993) Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor-alpha expression. Cancer Res 53:1939–1944PubMed Wu S, Boyer CM, Whitaker RS, Berchuch A, Wienberg JB, Bast RCJ (1993) Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor-alpha expression. Cancer Res 53:1939–1944PubMed
go back to reference Zeigler-Heitbrock HEL, Theil C, Haas JG, Moller A, Reith A, Muller G (1988) Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity. Nat Immun Cell Growth Regul 7:280–286PubMed Zeigler-Heitbrock HEL, Theil C, Haas JG, Moller A, Reith A, Muller G (1988) Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity. Nat Immun Cell Growth Regul 7:280–286PubMed
Metadata
Title
Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma
Authors
T. Valković
D. Fučkar
S. Štifter
K. Matušan
M. Hasan
F. Dobrila
N. Jonjić
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 7/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-004-0667-3

Other articles of this Issue 7/2005

Journal of Cancer Research and Clinical Oncology 7/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine